TFF Pharmaceuticals to Participate in the BTIG Virtual Biotechnology Conference
AUSTIN, Texas, July 28, 2021 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that its President and CEO, Glenn Mattes, will be available for one-on-one meetings and will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Monday, August 9, 2021 at 2:00pm EST.
BTIG Virtual Biotechnology Conference – August 9-10, 2021
If you are interested in arranging a one-on-one meeting, please contact your BTIG conference representative.
About TFF Pharmaceuticals
Investor Relations Contact:
Corey Davis, Ph.D.
Driving Production Lessons from the Automotive Industry
Lunch Vouchers Provided to Paid Conference Pass Holders, Exhibitors, Sponsors, Speakers, Press
Presentation Details TBA